MARKET

MEDS

MEDS

Trxade Health Inc
NASDAQ
6.45
-0.05
-0.77%
After Hours: 6.42 -0.03 -0.47% 16:00 04/24 EDT
OPEN
6.63
PREV CLOSE
6.50
HIGH
6.83
LOW
6.28
VOLUME
16.47K
TURNOVER
0
52 WEEK HIGH
29.75
52 WEEK LOW
2.464
MARKET CAP
9.07M
P/E (TTM)
-0.6466
1D
5D
1M
3M
1Y
5Y
TRxADE HEALTH receives Nasdaq notice regarding late filing of annual report
Seeking Alpha · 1d ago
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
Trxade Health, Inc. Received a notice from the Nasdaq Listing Qualifications Department on April 17, 2024. The Company was not compliant with the timely filing requirement for continued listing. The company had not yet filed its Annual Report on Form 10-K for the 2023 fiscal year.
Barchart · 1d ago
Financial Report: Overview of 0001382574's Financial Performance and Composition
Press release · 2d ago
Weekly Report: what happened at MEDS last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at MEDS last week (0408-0412)?
Weekly Report · 04/15 11:00
Weekly Report: what happened at MEDS last week (0401-0405)?
Weekly Report · 04/08 11:05
12 Health Care Stocks Moving In Friday's Intraday Session
Candel Therapeutics (NASDAQ:CADL) stock increased by 27.6% to $8.17 during Friday's regular session. The company's market cap stands at $239.6 million. Galectin Therapeutic shares increased by 20.66% and Ocugen stock moved upwards by 17.88%. Candel Therapeutical is one of the top gainers in the sector.
Benzinga · 04/05 16:31
TRXADE HEALTH - FOR YEAR ENDED DEC 31, 2023 SEES 10% DECREASE IN TOTAL REV, 8% INCREASE IN TOTAL OPERATING EXPENSES, 92% INCREASE IN OPERATING LOSS
Reuters · 04/02 20:32
More
About MEDS
TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.

Webull offers Trxade Health Inc stock information, including NASDAQ: MEDS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDS stock methods without spending real money on the virtual paper trading platform.